Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
5
×
software
5
×
boston blog main
boston top stories
biotech
cancer
clinical trials
detroit blog main
detroit top stories
national top stories
new york blog main
new york top stories
roche
wisconsin blog main
wisconsin top stories
deals
fda
healthcare
investing
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
tech
texas blog main
texas top stories
4490 ventures
a2 biotherapeutics
accelerator
accomplice
accuray
aduro biotech
advanced medical optics
What
bio
growing
ipo
medicines
admits
ago
alliance
analysis
bets
big
biotech
biotechs
bring
bristol
buy
calls
changing
classes
color
combinator
companies
company
company’s
course
crispr
days
develop
development
discover
diseases
drug
dug
employing
experimental
firm
fund
genetic
going
goldfinch
handiwork
Language
unset
5
×
Current search:
software
×
unset
×
" national blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Venture Investors Bets on Healthcare, and Milwaukee, With $75M Fund
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In